Lv4
710 积分 2025-07-27 加入
Natriuretic Peptide Receptor-1 Agonist for Resistant Hypertension
5天前
已完结
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
10天前
已完结
Prime Editing for p47 phox -Deficient Chronic Granulomatous Disease
12天前
已完结
Celiac Disease
12天前
已完结
Morpholylureas are a new class of potent and selective inhibitors of the type 5 17-β-hydroxysteroid dehydrogenase (AKR1C3)
14天前
已完结
Sight restored by turning back the epigenetic clock
15天前
已完结
Discovery of FLC-8 as the First Covalent FLT3 Inhibitor Targeting Cys807 for FLT3 Mutant Acute Myeloid Leukemia
15天前
已完结
GLP-1 Receptor Agonists
17天前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
27天前
已完结
Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trial
1个月前
已完结
皖公网安备34019202002308
